Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1998 2
1999 3
2000 2
2001 1
2002 3
2003 2
2004 3
2005 4
2006 4
2007 3
2008 3
2009 3
2010 1
2011 4
2012 5
2013 3
2014 5
2015 3
2016 8
2017 14
2018 13
2019 11
2020 8
2021 6
2022 8
2023 2
2024 6
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Molecular-based targeted therapies in patients with hepatocellular carcinoma and hepato-cholangiocarcinoma refractory to atezolizumab/bevacizumab.
Limousin W, Laurent-Puig P, Ziol M, Ganne-Carrié N, Nahon P, Ait-Omar A, Seror O, Sidali S, Campani C, Blanc P, Lermine A, Marisa L, Zucman-Rossi J, Nault JC. Limousin W, et al. Among authors: seror o. J Hepatol. 2023 Dec;79(6):1450-1458. doi: 10.1016/j.jhep.2023.08.017. Epub 2023 Aug 28. J Hepatol. 2023. PMID: 37647991
Reply.
Durand-Zaleski I, Bulsei J, Seror O, Nahon P. Durand-Zaleski I, et al. Among authors: seror o. Hepatology. 2017 Jul;66(1):300-301. doi: 10.1002/hep.29193. Epub 2017 May 26. Hepatology. 2017. PMID: 28380685 No abstract available.
[Cranial pachymeningitis].
Fain O, Seror O, Wirth JF, Heron C, Mathieu E, Chamouard JM, Guillevin L, Thomas M. Fain O, et al. Among authors: seror o. Rev Med Interne. 1999 Mar;20(3):234-46. doi: 10.1016/s0248-8663(99)83051-3. Rev Med Interne. 1999. PMID: 10216880 Review. French.
Macrotrabecular-massive hepatocellular carcinoma: A distinctive histological subtype with clinical relevance.
Ziol M, Poté N, Amaddeo G, Laurent A, Nault JC, Oberti F, Costentin C, Michalak S, Bouattour M, Francoz C, Pageaux GP, Ramos J, Decaens T, Luciani A, Guiu B, Vilgrain V, Aubé C, Derman J, Charpy C, Zucman-Rossi J, Barget N, Seror O, Ganne-Carrié N, Paradis V, Calderaro J. Ziol M, et al. Among authors: seror o. Hepatology. 2018 Jul;68(1):103-112. doi: 10.1002/hep.29762. Epub 2018 May 9. Hepatology. 2018. PMID: 29281854
Reply.
Nahon P, Seror O, Durand-Zaleski I. Nahon P, et al. Among authors: seror o. Hepatology. 2017 Jul;66(1):298-299. doi: 10.1002/hep.29174. Epub 2017 May 26. Hepatology. 2017. PMID: 28318039 No abstract available.
Association of LI-RADS and Histopathologic Features with Survival in Patients with Solitary Resected Hepatocellular Carcinoma.
Cannella R, Matteini F, Dioguardi Burgio M, Sartoris R, Beaufrère A, Calderaro J, Mulé S, Reizine E, Luciani A, Laurent A, Seror O, Ganne-Carrié N, Wagner M, Scatton O, Vilgrain V, Cauchy F, Hobeika C, Ronot M. Cannella R, et al. Among authors: seror o. Radiology. 2024 Feb;310(2):e231160. doi: 10.1148/radiol.231160. Radiology. 2024. PMID: 38411519
114 results